These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 18952841)
21. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Li Y; Gao L; Luo X; Wang L; Gao X; Wang W; Sun J; Dou L; Li J; Xu C; Wang L; Zhou M; Jiang M; Zhou J; Caligiuri MA; Nervi C; Bloomfield CD; Marcucci G; Yu L Blood; 2013 Jan; 121(3):499-509. PubMed ID: 23223432 [TBL] [Abstract][Full Text] [Related]
22. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein. Zhen T; Wu CF; Liu P; Wu HY; Zhou GB; Lu Y; Liu JX; Liang Y; Li KK; Wang YY; Xie YY; He MM; Cao HM; Zhang WN; Chen LM; Petrie K; Chen SJ; Chen Z Sci Transl Med; 2012 Mar; 4(127):127ra38. PubMed ID: 22461642 [TBL] [Abstract][Full Text] [Related]
23. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913 [TBL] [Abstract][Full Text] [Related]
24. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes. Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502 [TBL] [Abstract][Full Text] [Related]
25. C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice. Wang YY; Zhao LJ; Wu CF; Liu P; Shi L; Liang Y; Xiong SM; Mi JQ; Chen Z; Ren R; Chen SJ Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2450-5. PubMed ID: 21262832 [TBL] [Abstract][Full Text] [Related]
26. Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity. Lu Y; Peng ZG; Yuan TT; Yin QQ; Xia L; Chen GQ Leukemia; 2008 Feb; 22(2):378-86. PubMed ID: 17989718 [TBL] [Abstract][Full Text] [Related]
28. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627 [TBL] [Abstract][Full Text] [Related]
29. Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically. Zapotocky M; Mejstrikova E; Smetana K; Stary J; Trka J; Starkova J Cancer Lett; 2012 Jun; 319(2):144-153. PubMed ID: 22261333 [TBL] [Abstract][Full Text] [Related]
30. [Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype]. Miao YQ; Chen ZX; He J; Cen JN; Bao XJ; Qiu QC; Zhang DE; Yan M Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):27-9. PubMed ID: 17649722 [TBL] [Abstract][Full Text] [Related]
31. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465 [TBL] [Abstract][Full Text] [Related]
32. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288 [TBL] [Abstract][Full Text] [Related]
33. AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia. Zhou L; Wang Q; Chen X; Fu L; Zhang X; Wang L; Deng A; Li D; Liu J; Lv N; Wang L; Li Y; Liu D; Yu L; Dou L Exp Hematol; 2017 Feb; 46():62-69. PubMed ID: 27725192 [TBL] [Abstract][Full Text] [Related]
34. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia. Le XF; Claxton D; Kornblau S; Fan YH; Mu ZM; Chang KS Eur J Haematol; 1998 Apr; 60(4):217-25. PubMed ID: 9579874 [TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2. Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543 [TBL] [Abstract][Full Text] [Related]
38. Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. DeKelver RC; Yan M; Ahn EY; Shia WJ; Speck NA; Zhang DE Blood; 2013 May; 121(18):3714-7. PubMed ID: 23426948 [TBL] [Abstract][Full Text] [Related]
39. Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis. Liu N; Song J; Xie Y; Wang XL; Rong B; Man N; Zhang MM; Zhang Q; Gao FF; Du MR; Zhang Y; Shen J; Xu CH; Hu CL; Wu JC; Liu P; Zhang YL; Xie YY; Liu P; Huang JY; Huang QH; Lan F; Shen S; Nimer SD; Chen Z; Chen SJ; Roeder RG; Wang L; Sun XJ Proc Natl Acad Sci U S A; 2019 Jan; 116(3):890-899. PubMed ID: 30593567 [TBL] [Abstract][Full Text] [Related]
40. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Rhoades KL; Hetherington CJ; Rowley JD; Hiebert SW; Nucifora G; Tenen DG; Zhang DE Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11895-900. PubMed ID: 8876234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]